StaceyShackford, Author at Bionest

29

May 2023

Bionest

GLP-1 Agonists: The Next Pharma El Dorado? – Part 2

Will GLP-1 agents ultimately find success in NASH in addition to diabetes and obesity? We explore applications in liver disease in part two of our series.

28

Feb 2022

Bionest

Trends to Watch in 2022 after the 40th Annual JPM Conference

Fewer blockbuster M&A announcements, more early-stage partnerships & acquisitions. We examine trends for 2022 that emerged at JPM

28

Oct 2020

Bionest

Time to Embrace Decentralized Clinical Trials

A clearer roadmap for decentralized clinical trials will enable companies to better plan and more quickly advance their adoption of these strategies, which have the potential of benefiting patients and drug developers alike.

13

Jul 2020

Bionest

New Efforts Aimed at Increasing Generics Availability, Lowering Prices

Why have prices for certain generic drugs risen? And what is being done to increase availability while keeping costs in check?